Snowball logo
logo
NRXP

NRX Pharmaceuticals Inc

NRXP β€’ NASDAQ
$2.55+$0.06Β  (2.41%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
----1.2253.394
COGS
0.0020.0040.0050.0050.5052.285
Gross Profit
(0.002)(0.004)(0.005)(0.005)0.721.109
Operating Expenses & Income
Operating Income
(95.2)(44.34)(27.59)(19.7)(16.22)(19.96)
Total Operating Expenses
95.244.3327.5819.716.9421.07
R&D Expenses
20.2617.0313.376.1993.7775.412
Selling General & Admin Expenses
74.9427.3714.2213.5113.0615.94
Earnings from Continuing Operations
Interest Expense
(0.018)(4.581)(0.12)(1.079)(0.671)(1.144)
Interest Income
-0.2490.550.0440.0120.017
Income Tax Expense
(21.35)(4.581)(0.009)---
Net Income
Net Income
(93.06)(39.75)(30.15)(25.13)(28.62)(23.48)
Supplemental
EBIT
(93.05)(39.75)(30.03)(24.05)(27.95)(22.34)
EBITDA
(93.04)(39.75)(30.02)(24.04)(27.81)(21.96)
In millions of USD, except % and values per 1 share